ANAVEX LIFE SCIENCES CORP. Current Liabilities
ANAVEX LIFE SCIENCES CORP. (AVXL) had Current Liabilities of $9.48 million as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2022-08-09
- 2022-06-30: Liabilities, Current $9.48M.
- 2022-03-31: Liabilities, Current $8.07M.
- 2021-12-31: Liabilities, Current $10.53M.
- 2021-09-30: Liabilities, Current $10.80M.
| Period end | Liabilities, Current |
|---|---|
| 2022-06-30 | $9.48M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $8.07M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $10.53M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $10.80M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $7.76M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $8.03M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $7.31M 10-Q · filed 2021-05-13 |
| 2020-06-30 | $6.95M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $6.23M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.46M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $5.04M 10-Q · filed 2020-08-06 |
| 2019-06-30 | $4.34M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $6.37M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.88M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $3.88M 10-K · filed 2019-12-16 |
| 2018-06-30 | $3.21M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $3.42M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.80M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $3.58M 10-K · filed 2019-01-25 |
| 2017-06-30 | $1.45M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $2.12M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.19M 10-Q · filed 2017-02-07 |
| 2016-09-30 | $3.19M 10-Q · filed 2017-08-07 |
| 2016-06-30 | $2.17M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $2.43M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $2.53M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $2.66M 10-K · filed 2016-12-14 |
| 2015-06-30 | $1.35M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $1.53M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $1.42M 10-Q · filed 2015-02-17 |
| 2014-09-30 | $1.44M 10-K · filed 2015-12-29 |
| 2014-06-30 | $1.90M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $1.88M 10-Q/A · filed 2014-05-30 |
| 2013-12-31 | $1.82M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $1.95M 10-K · filed 2014-12-29 |
| 2012-09-30 | $2.89M 10-K · filed 2013-12-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |